DOSTARLIMAB-GXLY for Endometrial neoplasm: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

There are 6 adverse event reports in the FDA FAERS database where DOSTARLIMAB-GXLY was used for Endometrial neoplasm.

Most Reported Side Effects for DOSTARLIMAB-GXLY

Side Effect	Reports	%	Deaths	Hosp.
Off label use	51	10.1%	4	6
Rash	42	8.3%	1	11
Death	28	5.6%	28	1
Malignant neoplasm progression	28	5.6%	4	2
Fatigue	22	4.4%	2	4
Neuropathy peripheral	20	4.0%	0	0
Pyrexia	20	4.0%	0	9
Product use in unapproved indication	19	3.8%	3	7
Thrombocytopenia	16	3.2%	2	7
Hypothyroidism	14	2.8%	1	3
Erythema	13	2.6%	0	0
Colitis	12	2.4%	0	5
Dyspnoea	12	2.4%	3	2
Diarrhoea	11	2.2%	1	6
Pain	11	2.2%	2	2